C21 Investments Stock Five Year Return

Although Five Year Returns can give a sense of overall investment potential, it is recommended to compare equity performance with similar assets for the same five year time interval. Similarly, comparing overall investment performance over the last five years with the appropriate market index is a great way to determine how this equity instrument will perform during unforeseen market fluctuations.

According to the company disclosure, C21 Investments has a Five Year Return of 0.0%. This indicator is about the same for the Healthcare average (which is currently at 0.0) sector and about the same as Drug Manufacturers—Specialty & Generic (which currently averages 0.0) industry. This indicator is about the same for all United States stocks average (which is currently at 0.0).

The Macroaxis Fundamental Analysis modules help investors analyze C21 Investments's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of C21 Investments using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of C21 Investments based on its fundamental data. In general, a quantitative approach, as applied to this otc stock, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.

C21 Investments financial ratios help investors to determine whether C21 OTC Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in C21 with respect to the benefits of owning C21 Investments security.